• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然神经丝氨酸蛋白酶抑制剂的2.1埃晶体结构揭示了导致构象不稳定的独特结构元件。

The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability.

作者信息

Takehara Sayaka, Onda Maki, Zhang Juan, Nishiyama Mika, Yang Xiaoyan, Mikami Bunzo, Lomas David A

机构信息

Division of Applied Life Sciences, The Graduate School of Agriculture, Kyoto University, Uji 611-0011, Japan.

出版信息

J Mol Biol. 2009 Apr 24;388(1):11-20. doi: 10.1016/j.jmb.2009.03.007. Epub 2009 Mar 10.

DOI:10.1016/j.jmb.2009.03.007
PMID:19285087
Abstract

Neuroserpin is a selective inhibitor of tissue-type plasminogen activator (tPA) that plays an important role in neuronal plasticity, memory, and learning. We report here the crystal structure of native human neuroserpin at 2.1 A resolution. The structure has a helical reactive center loop and an omega loop between strands 1B and 2B. The omega loop contributes to the inhibition of tPA, as deletion of this motif reduced the association rate constant with tPA by threefold but had no effect on the kinetics of interaction with urokinase. Point mutations in neuroserpin cause the formation of ordered intracellular polymers that underlie dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB). Wild-type neuroserpin is also unstable and readily forms polymers under near-physiological conditions in vitro. This is, in part, due to the substitution of a conserved alanine for serine at position 340. The replacement of Ser340 by Ala increased the melting temperature by 3 degrees C and reduced polymerization as compared to wild-type neuroserpin. Similarly, neuroserpin has Asn-Leu-Val at the end of helix F and thus differs markedly from the Gly-X-Ile consensus sequence of the serpins. Restoration of these amino acids to the consensus sequence increased thermal stability and reduced the polymerization of neuroserpin and its transition to the latent conformer. Moreover, introduction of the consensus sequence into S49P neuroserpin that causes FENIB increased the stability and inhibitory activity of the mutant, as well as blocked polymerization and increased the yield of protein during refolding. These data provide a molecular explanation for the inherent instability of neuroserpin and the effect of point mutations that underlie the dementia FENIB.

摘要

神经丝氨酸蛋白酶抑制剂是组织型纤溶酶原激活剂(tPA)的选择性抑制剂,在神经元可塑性、记忆和学习中发挥重要作用。我们在此报告分辨率为2.1埃的天然人神经丝氨酸蛋白酶抑制剂的晶体结构。该结构具有螺旋反应中心环以及在1B和2B链之间的ω环。ω环有助于抑制tPA,因为缺失该基序会使与tPA的结合速率常数降低三倍,但对与尿激酶的相互作用动力学没有影响。神经丝氨酸蛋白酶抑制剂中的点突变会导致形成有序的细胞内聚合物,这是伴有神经丝氨酸蛋白酶抑制剂包涵体的痴呆性家族性脑病(FENIB)的基础。野生型神经丝氨酸蛋白酶抑制剂也不稳定,在体外接近生理条件下很容易形成聚合物。这部分是由于在340位将保守的丙氨酸替换为丝氨酸。与野生型神经丝氨酸蛋白酶抑制剂相比,将丝氨酸340替换为丙氨酸可使解链温度提高3摄氏度并减少聚合。同样,神经丝氨酸蛋白酶抑制剂在螺旋F末端具有天冬酰胺 - 亮氨酸 - 缬氨酸,因此与丝氨酸蛋白酶抑制剂的甘氨酸 - X - 异亮氨酸共有序列明显不同。将这些氨基酸恢复为共有序列可提高热稳定性并减少神经丝氨酸蛋白酶抑制剂的聚合及其向潜在构象的转变。此外,将共有序列引入导致FENIB的S49P神经丝氨酸蛋白酶抑制剂中,可提高突变体的稳定性和抑制活性,同时阻止聚合并提高重折叠过程中蛋白质的产量。这些数据为神经丝氨酸蛋白酶抑制剂的固有不稳定性以及作为痴呆性FENIB基础的点突变的影响提供了分子解释。

相似文献

1
The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability.天然神经丝氨酸蛋白酶抑制剂的2.1埃晶体结构揭示了导致构象不稳定的独特结构元件。
J Mol Biol. 2009 Apr 24;388(1):11-20. doi: 10.1016/j.jmb.2009.03.007. Epub 2009 Mar 10.
2
Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB.神经丝氨酸蛋白酶波特兰型(Ser52Arg)被困为一种无活性中间体,该中间体迅速形成聚合物:对痴呆症FENIB中所见癫痫的启示。
Eur J Biochem. 2004 Aug;271(16):3360-7. doi: 10.1111/j.1432-1033.2004.04270.x.
3
Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies.在伴有神经丝氨酸蛋白酶包涵体的痴呆型家族性脑病中,潜在的S49P神经丝氨酸蛋白酶会形成聚合物。
J Biol Chem. 2005 Apr 8;280(14):13735-41. doi: 10.1074/jbc.M413282200. Epub 2005 Jan 21.
4
Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.导致伴有神经丝氨酸蛋白酶包涵体的家族性脑病的突变神经丝氨酸蛋白酶(S49P)是一种低效的蛋白酶抑制剂,在体外很容易形成聚合物。
J Biol Chem. 2002 May 10;277(19):17367-73. doi: 10.1074/jbc.M200680200. Epub 2002 Mar 5.
5
A novel interaction between aging and ER overload in a protein conformational dementia.一种新型蛋白构象痴呆症中衰老与内质网过载的相互作用。
Genetics. 2013 Mar;193(3):865-76. doi: 10.1534/genetics.112.149088. Epub 2013 Jan 18.
6
Human neuroserpin: structure and time-dependent inhibition.人神经丝氨酸蛋白酶抑制剂:结构与时间依赖性抑制
J Mol Biol. 2009 Apr 24;388(1):109-21. doi: 10.1016/j.jmb.2009.02.056. Epub 2009 Mar 2.
7
Changes in strand 6B and helix B during neuroserpin inhibition: Implication in severity of clinical phenotype.神经丝氨酸蛋白酶抑制剂 6B 链和 B 螺旋结构的变化:对临床表型严重程度的影响。
Biochim Biophys Acta Proteins Proteom. 2020 Apr;1868(4):140363. doi: 10.1016/j.bbapap.2020.140363. Epub 2020 Jan 16.
8
The stability and activity of human neuroserpin are modulated by a salt bridge that stabilises the reactive centre loop.人神经丝氨酸蛋白酶抑制剂的稳定性和活性由一个稳定反应中心环的盐桥调节。
Sci Rep. 2015 Sep 2;5:13666. doi: 10.1038/srep13666.
9
Refolding and polymerization pathways of neuroserpin.神经丝氨酸蛋白酶抑制剂的重折叠和聚合途径。
J Mol Biol. 2010 Nov 12;403(5):751-62. doi: 10.1016/j.jmb.2010.07.047. Epub 2010 Aug 4.
10
A structural basis for loop C-sheet polymerization in serpins.丝氨酸蛋白酶抑制剂中C环片层聚合的结构基础。
J Mol Biol. 2008 Mar 7;376(5):1348-59. doi: 10.1016/j.jmb.2007.12.050. Epub 2008 Jan 3.

引用本文的文献

1
Strand 1A variant in neuroserpin shows increased aggregation and no loss of inhibition: implication in ameliorating polymerization to retain activity.神经丝氨酸蛋白酶抑制剂 1A 变异体显示出增加的聚集而没有抑制丧失:改善聚合以保留活性的意义。
Biosci Rep. 2022 Dec 22;42(12). doi: 10.1042/BSR20221825.
2
Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation.神经丝氨酸蛋白酶抑制因子和转甲状腺素蛋白是优先抑制淀粉样蛋白形成的细胞外伴侣蛋白。
Sci Adv. 2021 Dec 10;7(50):eabf7606. doi: 10.1126/sciadv.abf7606.
3
Neuroserpin: structure, function, physiology and pathology.
神经丝氨酸蛋白酶抑制剂:结构、功能、生理学和病理学。
Cell Mol Life Sci. 2021 Oct;78(19-20):6409-6430. doi: 10.1007/s00018-021-03907-6. Epub 2021 Aug 17.
4
Glycosylation Tunes Neuroserpin Physiological and Pathological Properties.糖基化调节神经丝氨酸蛋白酶抑制剂的生理和病理特性。
Int J Mol Sci. 2020 May 3;21(9):3235. doi: 10.3390/ijms21093235.
5
Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin.人类 KLK8/neuropsin 变构环网络的特异性和活性调节的结构决定因素。
Sci Rep. 2018 Jul 16;8(1):10705. doi: 10.1038/s41598-018-29058-6.
6
A hydrophobic patch surrounding Trp154 in human neuroserpin controls the helix F dynamics with implications in inhibition and aggregation.一个位于人神经丝氨酸蛋白酶抑制剂 Trp154 周围的疏水区控制着螺旋 F 的动力学,这对抑制和聚集有影响。
Sci Rep. 2017 Feb 23;7:42987. doi: 10.1038/srep42987.
7
Smoothing a rugged protein folding landscape by sequence-based redesign.通过基于序列的重新设计来平滑崎岖的蛋白质折叠景观。
Sci Rep. 2016 Sep 26;6:33958. doi: 10.1038/srep33958.
8
Neuroserpin Differentiates Between Forms of Tissue Type Plasminogen Activator via pH Dependent Deacylation.神经丝氨酸蛋白酶抑制剂通过pH依赖性脱酰作用区分组织型纤溶酶原激活剂的不同形式。
Front Cell Neurosci. 2016 Jun 15;10:154. doi: 10.3389/fncel.2016.00154. eCollection 2016.
9
AFM Imaging Reveals Topographic Diversity of Wild Type and Z Variant Polymers of Human α1-Proteinase Inhibitor.原子力显微镜成像揭示了人α1-抗胰蛋白酶野生型和Z变体聚合物的形貌多样性。
PLoS One. 2016 Mar 23;11(3):e0151902. doi: 10.1371/journal.pone.0151902. eCollection 2016.
10
Interactions between N-linked glycosylation and polymerisation of neuroserpin within the endoplasmic reticulum.内质网中N-连接糖基化与神经丝氨酸蛋白酶聚合之间的相互作用。
FEBS J. 2015 Dec;282(23):4565-79. doi: 10.1111/febs.13517. Epub 2015 Oct 3.